12,372 trials
Chronic Obstructive Pulmonary Disease (COPD)
Primary: Forced Expiratory Volume in 1 Second (FEV1) Standardized (With Respect to Length of Time) Area Under the Curve (AUC) From 5 Minutes to 8 Hours Post-dose at the End of…
Chronic Obstructive Pulmonary Disease
Primary: Trough Forced Expiratory Volume in 1 Second (FEV1) 24 Hours Post-dose at the End of Each Treatment Period (Day 15) — 1.46; 1.26; 1.37 Liters
Chronic Obstructive Pulmonary Disease
Primary: Trough Forced Expiratory Volume in 1 Second (FEV1) 24 Hours Post-dose at the End of the Study (Week 12 + 1 Day, Day 85) — 1.48; 1.35 Liters
Anesthesia, General · Neuromuscular Blockade
Primary: Time From Start of Administration of Investigational Medicinal Product (IMP) to Recovery of the T4/T1 Ratio to 0.9. — 1.4; 6.7; 1.6; 9.1 minutes
COPD
Primary: The Number of Participants With a Clinically Notable Pulse Rate During 52 Weeks of Treatment With Indacaterol 150 µg or 300 µg Compared to Placebo — 3; 3; 2; 0…
Chronic Obstructive Pulmonary Disease
Primary: Trough Forced Expiratory Volume in 1 Second (FEV1) at Week 12 + 1 Day, Day 85 — 1.48; 1.48; 1.38; 1.31 Liters
Chronic Obstructive Pulmonary Disease (COPD)
Primary: Forced Expiratory Volume in 1 Second (FEV1) Standardized (With Respect to Time) Area Under the Curve (AUC) From 5 Minutes to 11 Hours 45 Minutes Post-dose at the End of…
Chronic Obstructive Pulmonary Disease (COPD)
Primary: 24-hour Post-dose Trough Forced Expiratory Volume in 1 Second (FEV1) After 14 Days of Treatment — 1.53; 1.51; 1.48; 1.36 Liters
Infection, Human Immunodeficiency Virus I · HIV Infection
Primary: Percentage of Participants (PAR) Who Achieved Plasma HIV-1 RNA <50 Copies (c) /Milliliter (ml) at the Week 84 Visit — 86; 81 percentage of participants — p=0.140
Chronic Obstructive Pulmonary Disease (COPD)
Primary: Trough Forced Expiratory Volume in 1 Second (FEV1) Following 14 Days of Evening Dosing of Indacaterol Versus Placebo — 1.57; 1.37 Liters
Chronic Obstructive Pulmonary Disease (COPD)
Primary: Trough Forced Expiratory Volume in 1 Second (FEV1) at Week 12 + 1 Day, Day 85 — 1.32; 1.29; 1.17 Liters
Chronic Obstructive Pulmonary Disease
Primary: Exercise Duration Time Assessed by Constant-load Cycle Ergometry at the End of Each Treatment Period — 586; 475 Seconds
Healthy
Primary: Number of Days Children Are Out of School Sick — 2.51; 2.82 days per 100 person days
Chronic Obstructive Pulmonary Disease (COPD)
Primary: Trough Forced Expiratory Volume in 1 Second (FEV1) 24 Hours Post-dose at the End of Treatment (Week 12 + 1 Day, Day 85) — 1.34; 1.37; 1.17 Liters
Chronic Obstructive Pulmonary Disease
Primary: Forced Expiratory Volume in 1 Second (FEV1) at 5 Minutes Post-dose — 1.48; 1.50; 1.38; 1.43 Liters